{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:41:46Z","timestamp":1768470106865,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ccep.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T20:38:13Z","timestamp":1428611893000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Arrhythmias in Fabry Cardiomyopathy"],"prefix":"10.1016","volume":"7","author":[{"given":"Deepak","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Doppalapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Tallaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ccep.2015.03.014_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.ccep.2015.03.014_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.ccep.2015.03.014_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2009.11.002","article-title":"Anderson-Fabry disease and the heart","volume":"52","author":"O'Mahony","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ccep.2015.03.014_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.ccep.2015.03.014_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ultrasmedbio.2008.10.010","article-title":"Heart valve involvement in Fabry cardiomyopathy","volume":"35","author":"Weidemann","year":"2009","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CRD.0b013e31818adc50","article-title":"Fabry disease: cardiac manifestations and therapeutic options","volume":"17","author":"Pierre-Louis","year":"2009","journal-title":"Cardiol Rev"},{"issue":"6","key":"10.1016\/j.ccep.2015.03.014_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ccep.2015.03.014_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM197308162890709","article-title":"The abbreviated PR interval of Fabry's disease","volume":"289","author":"Roudebush","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccep.2015.03.014_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/000331977802900709","article-title":"Accelerated atrioventricular conduction in Fabry's disease: a case report","volume":"29","author":"Rowe","year":"1978","journal-title":"Angiology"},{"key":"10.1016\/j.ccep.2015.03.014_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000400453","article-title":"Electrocardiographic and vectorcardiographic observations in Fabry's disease","volume":"21","author":"Mehta","year":"1978","journal-title":"Adv Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-0736(82)80010-1","article-title":"Electrocardiograms in Fabry's disease","volume":"15","author":"Sheth","year":"1982","journal-title":"J\u00a0Electrocardiol"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-8703(90)90096-G","article-title":"Combined atrioventricular block and sinus node dysfunction in Fabry's disease","volume":"120","author":"Suzuki","year":"1990","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib13","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/heart.89.1.e2","article-title":"Sisters with atypical Fabry's disease with complete atrioventricular block","volume":"89","author":"Doi","year":"2003","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM200303203481224","article-title":"PR interval and the response to enzyme-replacement therapy for Fabry's disease","volume":"348","author":"Waldek","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00392-009-0084-3","article-title":"Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy","volume":"99","author":"Prinz","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2015.03.014_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.amjcard.2009.10.056","article-title":"PQ interval in patients with Fabry disease","volume":"105","author":"Namdar","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2015.03.014_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/hrt.2010.211789","article-title":"Electrocardiographic changes in early recognition of Fabry disease","volume":"97","author":"Namdar","year":"2011","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ccep.2015.03.014_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10545-012-9540-8","article-title":"Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease","volume":"36","author":"Niemann","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijcard.2003.10.065","article-title":"Atrioventricular conduction disturbances in a young patient with Fabry's disease without other signs of cardiac involvement","volume":"99","author":"Kouris","year":"2005","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2015.03.014_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/hrt.68.9.323","article-title":"Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system","volume":"68","author":"Ikari","year":"1992","journal-title":"Br Heart J"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/europace\/eur267","article-title":"Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease","volume":"13","author":"O'Mahony","year":"2011","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2015.03.014_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib24","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.healun.2005.11.080","article-title":"Congestive heart failure in Fabry cardiomyopathy: natural history experience in an international cohort of 1,448 patients","volume":"25","author":"Pinderski","year":"2006","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"726","key":"10.1016\/j.ccep.2015.03.014_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/pgmj.62.726.285","article-title":"Short PR intervals and tachyarrhythmias in Fabry's disease","volume":"62","author":"Efthimiou","year":"1986","journal-title":"Postgrad Med J"},{"issue":"21","key":"10.1016\/j.ccep.2015.03.014_bib26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/hrt.2010.196162","article-title":"Atrial biopsy evidence of Fabry disease causing lone atrial fibrillation","volume":"96","author":"Chimenti","year":"2010","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib27","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCULATIONAHA.107.723387","article-title":"Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue","volume":"116","author":"Frustaci","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib28","first-page":"139","article-title":"Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia","volume":"54","author":"Fukuzawa","year":"2009","journal-title":"J\u00a0Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2015.03.014_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","author":"Weidemann","year":"2013","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0002-9149(94)90106-6","article-title":"Electrophysiologic findings in Fabry's disease with a short PR interval","volume":"74","author":"Pochis","year":"1994","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/europace\/eul121","article-title":"Electrophysiological study in a patient with Fabry disease and a short PQ interval","volume":"8","author":"Jastrzebski","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2015.03.014_bib32","first-page":"5S","article-title":"WPW and Fabry's disease: evidence foratrioventricular and atriohisian accessory pathway conduction","volume":"3","author":"Omar","year":"2006","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.ccep.2015.03.014_bib33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1540-8159.2008.01088.x","article-title":"Short PR interval in the absence of preexcitation: a characteristic finding in a patient with Fabry disease","volume":"31","author":"Aryana","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccep.2015.03.014_bib35","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hrthm.2010.08.006","article-title":"Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease","volume":"8","author":"Higashi","year":"2011","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.ccep.2015.03.014_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/AC.67.4.2170694","article-title":"Electrophysiological findings in Fabry cardiomyopathy: mapping the maze of risk stratification","volume":"67","author":"Li","year":"2012","journal-title":"Acta Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib38","first-page":"50","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J\u00a0Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2015.03.014_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.ccep.2015.03.014_bib40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.amjcard.2010.07.016","article-title":"When should cardiologists suspect Anderson-Fabry disease?","volume":"106","author":"Gambarin","year":"2010","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.ccep.2015.03.014_bib41","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/CIRCULATIONAHA.108.841494","article-title":"Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy","volume":"119","author":"Thurberg","year":"2009","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ccep.2015.03.014_bib42","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccep.2015.03.014_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.ccep.2015.03.014_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of\u00a0enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ccep.2015.03.014_bib46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/gim.2013.53","article-title":"Analysis of left ventricular mass in untreated men and in men treated with agalsidase-beta: data from the Fabry Registry","volume":"15","author":"Germain","year":"2013","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.ccep.2015.03.014_bib47","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"issue":"39","key":"10.1016\/j.ccep.2015.03.014_bib48","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on\u00a0diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force Members","year":"2014","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccep.2015.03.014_bib49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","article-title":"Relation of\u00a0burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease","volume":"114","author":"Kramer","year":"2014","journal-title":"Am J Cardiol"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187791821500043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187791821500043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T02:03:21Z","timestamp":1566525801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187791821500043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S187791821500043X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2015.03.014","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arrhythmias in Fabry Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}